Skip to main content

Advertisement

Contact David Pasquier

From: BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

Contact corresponding author